• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodies.

作者信息

Ginsbourg M, Musset M, Misset J L, Genty O, Mathé G

出版信息

Suppl J Med Oncol Tumor Pharmacother. 1988;1:51-4.

PMID:3074227
Abstract
摘要

相似文献

1
Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodies.骨髓中乳腺转移细胞作为微小残留病标志物的鉴定及其增殖指数作为预后因素的研究——一项使用单克隆抗体的免疫细胞学研究
Suppl J Med Oncol Tumor Pharmacother. 1988;1:51-4.
2
Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodies.骨髓中乳腺转移细胞的鉴定作为微小残留病的标志物及其增殖指数作为预后因素——一项使用单克隆抗体的免疫细胞学研究
Bull Soc Sci Med Grand Duche Luxemb. 1989 Mar-Apr;126(1):51-4.
3
Simultaneous detection in the bone marrow of mammary cancer metastatic cells and of their labelling index as respective markers of the residual minimum submacroscopic disease and its proliferative condition (preliminary results).同时检测乳腺癌转移细胞在骨髓中的存在及其标记指数，以此作为残余最小亚宏观疾病及其增殖状态的各自标志物（初步结果）。
Biomed Pharmacother. 1986;40(10):386-8.
4
Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer.用单克隆抗体检测乳腺癌患者的骨髓微转移。
Anticancer Res. 1990 Jan-Feb;10(1):119-21.
5
Relationship between proliferative activity of bone marrow micrometastasis and plasmatic level of a new cancer marker: lipid associated sialic acid (LASA) in human breast cancer.人乳腺癌骨髓微转移的增殖活性与一种新型癌症标志物——脂质相关唾液酸（LASA）血浆水平之间的关系。
Biomed Pharmacother. 1986;40(10):388-91.
6
Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow.人骨髓中乳腺癌细胞免疫细胞化学检测的敏感性
Cancer Res. 1991 May 15;51(10):2706-9.
7
Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system.免疫荧光单克隆抗体检测骨髓中的乳腺癌：模型系统中的敏感性
Cancer Res. 1989 May 1;49(9):2510-3.
8
Detection and management of bone marrow micrometastases in breast cancer.乳腺癌骨髓微转移的检测与管理
Oncology (Williston Park). 1994 Aug;8(8):25-31; discussion 35-6, 39-42.
9
Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.乳腺癌患者微小残留病的骨髓和淋巴结评估
Cancer Treat Rev. 2000 Feb;26(1):53-65. doi: 10.1053/ctrv.1999.0150.
10
Rating of isolated disseminated tumor cells in bone marrow in comparison with other factors of prognosis in breast carcinoma.与乳腺癌其他预后因素相比，骨髓中孤立性播散肿瘤细胞的分级
Int J Surg Investig. 2000;2(3):193-202.